Celldex Therapeutics reported 730K in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
AbbVie USD 9.34B 1.36B Mar/2025
Amgen USD 6.17B 624M Jun/2025
Bristol-Myers Squibb USD 8.9B 714M Jun/2025
Celldex Therapeutics 730K 35K Jun/2025
Glaxosmithkline GBP 5.83B 232M Jun/2025
Pfizer USD 10.88B 248M Jun/2025
Roche Holding CHF 11.69B 48M Dec/2024